Clinical Trial Update: Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar Disorder [Phase 4]

View source ↗

Summary

A Phase 4 trial of ziprasidone for generalized anxiety disorder in patients with bipolar disorder was terminated, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Generalized Anxiety Disorder

Drugs mentioned

• Ziprasidone (ziprasidone)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Generalized Anxiety Disorder, Bipolar Disorder | Phase 4 | Status: TERMINATED | Results posted: 2014-04-16